AMP updates pathology residency curriculum recommendations
BETHESDA, Md. – Feb. 5, 2016 – The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, has updated its pathology residency curriculum recommendations for 10 critical molecular pathology topics. The Journal of Molecular Diagnostics today published the AMP paper titled, "A Suggested Molecular Pathology Curriculum for Residents: A Report of the Association for Molecular Pathology."
Developed by a task force of the AMP Training and Education Committee, the latest report is intended to be an update to the original curriculum guidance published by the committee in 1999. The paper provides residency programs with specific recommendations from subject matter experts on 10 major molecular pathology topics: basic molecular pathology goals and laboratory management; basic concepts in molecular biology and genetics; technology; inherited disorders; oncology; infectious diseases; pharmacogenetics; histocompatibility and identity; genomics, and information management.
"Molecular pathology is a rapidly evolving area that has the potential to revolutionize the way healthcare is delivered and, as a result, has become an essential and growing component of pathology residency programs," said Charles E. Hill, MD, PhD, AMP President and corresponding author of the paper. "As the voice of molecular diagnostics professionals, AMP remains committed to ensuring medical schools and residency programs are able to incorporate the latest scientific breakthroughs and technological innovations in molecular pathology. This report is another great example of how we are bringing together the subject matter experts to address today's key issues so that pathologists are better equipped to handle the cases tomorrow."
To read the full paper, please visit: http://dx.doi.org/10.1016/j.jmoldx.2015.10.006
The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,300+ members include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees. Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing. For more information, visit http://www.amp.org.